Navigation Links
Less-Invasive Surgery for Esophageal Cancer Might Be Safer
Date:4/30/2012

MONDAY, April 30 (HealthDay News) -- Besides being easier on the patient, minimally invasive surgery to remove the esophagus of patients with esophageal cancer can also greatly reduce the risk of lung infection compared to traditional open surgery, a new study finds.

Dutch researchers also found that patients who undergo this less-invasive procedure have much shorter hospital stays and a better short-term quality of life than those who have open surgery, which requires cutting through a patient's chest.

One U.S. expert was impressed with the findings. The study "goes a long way to encouraging esophageal surgeons to seriously consider minimally invasive surgery for their patients with surgically resectable [removable] esophageal cancers," said Dr. Jonathan Aviv, clinical director of the Voice and Swallowing Center at Mount Sinai Medical Center in New York City.

Removal of part of or the entire esophagus (a procedure called esophagectomy) is the mainstay of esophageal cancer treatment. This study compared open esophagectomy and minimally invasive esophagectomy.

The minimally invasive procedure was first used two decades ago but this is the first study to compare minimally invasive and open esophagectomy, according to Miguel Cuesta, of the VU University Medical Centre in Amsterdam, and colleagues.

The researchers looked at the outcomes of 56 patients who had open surgery and 59 patients who had the minimally invasive procedure. In the two weeks after surgery, lung (or pulmonary) infections occurred in 29 percent of those who had open surgery but only 9 percent of those who had minimally invasive surgery.

Overall, 34 percent of the patients who had open surgery developed a lung infection, compared with 12 percent of those who underwent minimally invasive surgery, the study found.

The researchers also noted that patients who had minimally invasive surgery had less blood loss, far shorter hospital stays, and better quality of life (much less pain and vocal-cord paralysis).

Importantly, minimally invasive surgery was as effective as open surgery, the study authors concluded in the report published online April 30 in The Lancet.

"If these results can be confirmed in other settings, minimally invasive esophagectomy could truly become the standard of care," Simon Law, of the University of Hong Kong, China, wrote in an accompanying editorial.

For his part, Aviv also believes that the study "underscores the need for continued early screening of patients with symptoms suggestive of esophageal cancer -- cough and hoarseness, likely even more important than 'typical' gastrointestinal symptoms such as heartburn and regurgitation."

Aviv, who is also clinical professor of otolaryngology at Mount Sinai Medical Center, added that "esophageal cancer both in western Europe and here in the USA is the only cancer that is markedly increasing in incidence the past 30 years."

More information

The U.S. National Cancer Institute has more about esophageal cancer.

-- Robert Preidt

SOURCES: Jonathan E. Aviv, M.D., F.A.C.S., clinical director, Voice and Swallowing Center ENT and Allergy Associates, and clinical professor, otolaryngology, Mount Sinai Medical Center, New York City; The Lancet, news release, April 30, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Less-invasive Lymph Node Resection Following Breast Cancer Surgery Confirmed as Standard of Care in Eight-year Study Led by AGH Doctors
2. Repeated Weight-Loss Surgery Carries Added Risks
3. The New Liposuction Technique Means No Surgery or Suction
4. Research validates surgery alone offers reasonable overall survival for stage I SCLC
5. "New Cosmetic Surgery" Journalism Prize
6. Abington Memorial Hospital Welcomes Vakil to Orthopaedic Surgery Division
7. Drug for advanced kidney cancer shrinks tumors prior to surgery
8. Abington Memorial Hospital Earns Two Designations: Blue Distinction Center for Spine Surgery(SM) and Blue Distinction Center for Knee and Hip Replacement(SM)
9. New endoscopic treatment may spare Barretts esophagus patients from surgery
10. Pittsburgh Neurosurgeons Explore Use of Drug that Illuminates Brain Tumor Cells To Guide Surgery
11. Surgery Alone May Thwart Stage 1 Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Less-Invasive Surgery for Esophageal Cancer Might Be Safer
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment ... Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... General Manager of Astellas Farma Colombia ... ...
Breaking Medicine Technology: